<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02353182</url>
  </required_header>
  <id_info>
    <org_study_id>35014</org_study_id>
    <nct_id>NCT02353182</nct_id>
  </id_info>
  <brief_title>The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.</brief_title>
  <official_title>An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Murdoch Childrens Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Texas Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Royal Children's Hospital Melbourne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sydney Children's Hospitals Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Princess Margaret Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Starship Children's Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gaslini Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KK Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Murdoch Childrens Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Animal studies suggest general anaesthetics harm the developing brain. It is unclear if these
      findings are relevant to humans but the issue has become a major concern. Recent data have
      found that monkeys exposed to anaesthesia as infants grow up to have slower learning than
      those not exposed.

      The aim of the TREX pilot study is to determine the feasibility of an alternative anaesthetic
      regimen for lower abdominal/lower extremity surgery in infants 1-12 months of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Animal studies suggest general anaesthetics harm the developing brain. It is unclear if these
      findings are relevant to humans but the issue has become a major concern. Recent data have
      found that monkeys exposed to anaesthesia as infants grow up to have slower learning than
      those not exposed.

      The aim of the TREX pilot study is to determine the feasibility of an alternative anaesthetic
      regimen for lower abdominal/lower extremity surgery in infants 1-12 months of age.

      An alternative anaesthetic regimen comprises a dexmedetomidine-based anaesthetic, augmented
      with an opioid (remifentanil) and a regional nerve block (such as a caudal).

      This open label prospective single arm pilot study will enrol 60 infants aged 1-12 months
      scheduled for lower limb, urologic, or lower abdominal surgery. After sevoflurane induction,
      the infants will have a caudal anaesthetic and intravenous dexmedetomidine and remifentanil.

      The outcome will be need for intervention for light anaesthesia, intervention for
      haemodynamic changes and rate of abandoning the protocol. Recovery times will also be
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who need for intervention for light anaesthesia</measure>
    <time_frame>120 minutes (duration of surgery)</time_frame>
    <description>Rescue treatment for light anaesthesia will be given if hypertension MAP &gt; 80 mmHg (confirmed with repeated measure) and/or patient movement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants who need for intervention for haemodynamic changes</measure>
    <time_frame>120 minutes (duration of surgery)</time_frame>
    <description>Rescue treatment for mild Hypotension will be given if MAP is between 40 mmHg and &lt;50 mmHg (confirmed with repeated measure)
Moderate Hypotension will be defined as MAP &lt;40 mmHg
Mild bradycardia will be defined as HR &lt;100 bpm for over one minute
Significant bradycardia will be defined as &lt;70 bpm over one minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recovery after anaesthesia</measure>
    <time_frame>Time from last dressing to: eye opening, removal of airway device, first feed, and a modified Aldrete Score of 9-10 (average 30 minutes-4 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have respiratory complications</measure>
    <time_frame>Start of anaesthesia until discharge from PACU (average 1-4 hours)</time_frame>
    <description>Any episode of coughing, oxygen desaturation &lt;90%, breath holding &gt; 15 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have pain after anaesthesia</measure>
    <time_frame>End of surgery until discharge from PACU ( average 1-4 hours)</time_frame>
    <description>FLACC (Face, Legs, Activity, Cry, Consolability) scale. The scale is scored in a range of 0-10 with 0 representing no pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who require rescue analgesia in PACU</measure>
    <time_frame>End of surgery until discharge from PACU (average 1-4 hours)</time_frame>
    <description>Analgesia: morphine 0.025-0.05 mg/kg IV for analgesia; repeat 20 minutes. Analgesia thereafter as per local protocol</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Surgical Procedures, Operative</condition>
  <arm_group>
    <arm_group_label>Active open label single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine- remifentanil- caudal based anaesthetic for lower abdominal/lower extremity surgery.
Dexmedetomidine (Precedex): loading dose: 1 mcg/kg over 10 minutes. Infusion: Start 1 mcg/kg/hr; titrate up or down within 50% of starting doses as needed
Remifentanil (Ultiva): loading dose: 1 mcg/kg over 1-2 minutes. Infusion: Start at 0.2 mcg/kg/min. Titrate up or down (max 0.5 mcg/kg/min) as needed
Caudal- Bupivacaine (Marcaine) 0.175%-0.25% or Ropivacaine (Naropin) 0.2% with dose at discretion of anaesthetist</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Loading dose:1 mcg/kg over 10 minutes. Infusion: Start 1-1.5 mcg/kg/hr. Titrate up or down within 50% of starting doses as needed.</description>
    <arm_group_label>Active open label single arm</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Loading dose: 1 mcg/kg over 1-2 minutes. Infusion: Start at 0.2-0.5 mcg/kg/min. Titrate up or down (max 0.5 mcg/kg/min) as needed.</description>
    <arm_group_label>Active open label single arm</arm_group_label>
    <other_name>Ultiva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Administered in caudal/epidural/field block: 0.175%-0.25% (dose at discretion of anaesthetist)</description>
    <arm_group_label>Active open label single arm</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Administered in caudal/epidural/field block: 0.2% (dose at discretion of anaesthetist)</description>
    <arm_group_label>Active open label single arm</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants aged 1 to 12 months (corrected age)

          -  ASA I or II

          -  Infants undergoing lower abdominal/lower extremity surgery anticipated to be &gt; 120
             minutes in duration

          -  Surgery requires caudal regional nerve block

        Exclusion Criteria:

          -  ASA III or higher

          -  Any contraindication to caudal analgesia

          -  Any contraindication to an inhalational induction with sevoflurane

          -  Allergies to any medication in study protocol

          -  Planned admission to an ICU postoperatively (except level II or III neonatal ICU)

          -  Planned tracheal intubation postoperatively

          -  Mechanical ventilation postoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew J Davidson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Murdoch Childrens Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KK Women's and Children's Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>229899</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Singapore</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abdominal</keyword>
  <keyword>lower extremity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be presented as group data and no individual will be identified.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

